Free 7-day Trial
All Articles and Columns »

Weekly CFO Sells Highlight: KO, KKD, PIR, NPSP, ACAD

GuruFocus

gurujx

1 followers
According to GuruFocus Insider Data, the largest CFO sells during the past week were: Coca-Cola Co., Krispy Kreme Doughnuts Inc., Pier 1 Imports Inc., NPS Pharmaceuticals Inc. and ARCADIA Pharmaceuticals Inc.

Coca-Cola Co. (KO): Executive Vice President and CFO Gary P. Fayard Sold 224,000 Shares

Executive Vice President and CFO Gary P. Fayard sold 224,000 shares of KO stock on 04/09/2013 at the average price of $41. Gary P. Fayard owns at least 545,541 shares after this. The price of the stock has increased by 0.2% since.

The Coca-Cola Co. was incorporated in September 1919 under the laws of the State of Delaware. Coca-cola Co. has a market cap of $183.08 billion; its shares were traded at around $41.08 with a P/E ratio of 20.8333 and P/S ratio of 3.9216. The dividend yield of Coca-cola Co. stocks is 2.54%. Coca-Cola Co. had an annual average earnings growth of 9.6% over the past 10 years. GuruFocus rated Coca-Cola Co. the business predictability rank of 5-star.

Coca-Cola has released its fourth quarter 2012 results. Fourth quarter net revenues grew 4%. EPS for this quarter were $0.41, up 14% from the prior year quarter.

Krispy Kreme Doughnuts Inc. (KKD): CFO Douglas R. Muir Sold 120,000 Shares

CFO Douglas R. Muir sold 120,000 shares of KKD stock on 04/04/2013 at the average price of $14.18. Douglas R. Muir owns at least 78,177 shares after this. The price of the stock has increased by 5.85% since.

Krispy Kreme Doughnuts Inc. was incorporated in the State of North Carolina. Krispy Kreme Doughnuts Inc. has a market cap of $979.011 million; its shares were traded at around $15.01 with a P/E ratio of 6.6269 and P/S ratio of 2.5189. Krispy Kreme Doughnuts Inc. had an annual average earnings growth of 34.5% over the past five years.

Krispy Kreme Doughnuts has released its fourth quarter 2013 results ended Feb. 3, 2013. Revenues in this quarter were $118.1 million, up 15% from the $102 million reported prior year quarter. Adjusted net income was $7.4 million this quarter ($0.11 per share), up from the $4 million ($0.06 per share) reported last year. Same store sales grew 7.5% year over year.

Pier 1 Imports Inc. (PIR): Senior Executive Vice President and CFO Charles H. Turner Sold 63,000 Shares

Senior Executive Vice President and CFO Charles H. Turner sold 63,000 shares of PIR stock on 04/11/2013 at the average price of $23.84. Charles H. Turner owns at least 240,794 shares after this. The price of the stock has decreased by 2.73% since.

Pier 1 Imports Inc. was incorporated as a Delaware corporation in 1986. Pier 1 Imports Inc. has a market cap of $2.45 billion; its shares were traded at around $23.19 with a P/E ratio of 13.8313 and P/S ratio of 1.5528. The dividend yield of Pier 1 Imports Inc. stocks is 0.73%.

Pier 1 Imports Inc. recently released its fourth quarter 2013 results for the quarter ended March 2, 2013. Net income was $61.7 million ($0.58 per share), compared to $115.2 million ($1.04 per share) prior year quarter. Non-GAAP adjusted income was $64.2 million ($0.60 per share), compared to $61.5 million ($0.48) in the fourth quarter of 2012. Total sales increased 15.7% to $551.6 million.

President and CEO Alex Smith sold 70,000 shares of PIR stock on 04/11/2013 at the average price of $23.57.

NPS Pharmaceuticals Inc. (NPSP): Executive Vice President and CFO Luke M. Beshar Sold 50,000 Shares

Executive Vice President and CFO Luke M. Beshar sold 50,000 shares of NPSP stock on 04/10/2013 at the average price of $12. Luke M. Beshar owns at least 59,180 shares after this. The price of the stock has increased by 1.25% since.

NPS Pharmaceuticals Inc. is a biopharmaceutical company, which is focused on the development of new treatment options for patients with rare gastrointestinal and endocrine disorders and serious unmet medical needs. NPS Pharmaceuticals Inc. has a market cap of $1.06 billion; its shares were traded at around $12.15 with and P/S ratio of 8.0906.

NPS Pharmaceuticals Inc. reported fourth quarter 2012 net loss of $0.14 per share, on revenue growth of 3.5% to $27.2 million.

President, CEO and Director Francois Nader sold 448,367 shares of NPSP stock on 04/10/2013 at the average price of $11.31. Vice President Technical Operations Joseph J. Rogus sold 48,015 shares of NPSP stock on 04/09/2013 at the average price of $11.5.

ACADIA Pharmaceuticals Inc. (ACAD): Executive Vice President, CFO and CBO Thomas H. Aasen Sold 40,000 Shares

Executive Vice President, CFO and CBO Thomas H. Aasen sold 40,000 shares of ACAD stock on 04/11/2013 at the average price of $11.06. Thomas H. Aasen owns at least 44,500 shares after this. The price of the stock has increased by 13.38% since.

ACADIA Pharmaceuticals Inc. was originally incorporated in Vermont in 1993 as Receptor Technologies Inc. Acadia Pharmaceuticals Inc. has a market cap of $987.626 million; its shares were traded at around $12.54 with and P/S ratio of 140.845.

For its fourth quarter 2012, ACADIA Pharmaceuticals Inc. reported net loss of $6.8 million ($0.11 per share), compared to a loss of $5.3 million ($0.10 per share) in the same quarter of last year. Revenues were $380,000 this quarter, compared to $588,000 prior year quarter.

CEO Uli Hacksell and Vice President Glenn Baity both also recently sold shares of ACAD stock.

For the complete list of stocks that were sold by their CFOs, go to: Insider Buys.


Rating: 2.5/5 (4 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide